CA
NZ
UK
AU
IND
US
…
RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
RAMM Pharma Corp is a Canadian-listed pharmaceutical company focused on drug development and related commercialization activities; public disclosures about its pipeline and operations are limited. Long-term growth may be driven by clinical progress, regulatory approvals, licensing agreements and commercialization partnerships that could support value creation. Investors may find exposure to potential upside in biopharma development attractive while recognizing long timelines and binary outcomes.
The most important risks are early-stage development and regulatory binary risk combined with likely need for additional financing, limited public information and low trading liquidity.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Income before tax | -8.89M | -16.49M | -7.71M | -20.95M | -7.10M |
| Net income | -8.91M | -16.50M | -7.72M | -20.96M | -7.11M |
| Selling general administrative | 4.58M | 7.30M | 6.06M | 7.23M | 5.69M |
| Gross profit | 1.07M | 1.76M | 0.39M | 0.53M | -0.01M |
| Reconciled depreciation | 0.73M | 1.21M | 1.34M | 1.02M | 0.73M |
| Ebit | - | - | - | -7.94M | -6.64M |
| Ebitda | - | - | - | -19.92M | -6.36M |
| Operating income | -4.29M | -6.75M | -7.07M | -7.93M | -6.64M |
| Interest expense | 0.24M | 0.04M | 0.05M | 0.01M | 0.01M |
| Tax provision | 0.02M | 0.01M | 0.01M | 0.01M | 0.01M |
| Interest income | 0.01M | 0.03M | 0.20M | 0.16M | 0.27M |
| Net interest income | -0.25M | -0.03M | 0.12M | 0.14M | 0.25M |
| Income tax expense | - | - | - | 0.01M | 0.01M |
| Total revenue | 3.36M | 4.34M | 5.07M | 3.90M | 4.12M |
| Total operating expenses | 7.65M | 11.09M | 12.13M | 11.82M | 10.76M |
| Cost of revenue | 2.29M | 2.58M | 4.67M | 3.37M | 4.12M |
| Total other income expense net | -4.35M | -9.72M | -0.77M | -13.16M | -0.71M |
| Net income from continuing ops | -8.91M | -16.50M | -7.72M | -20.96M | -7.11M |
| Net income applicable to common shares | - | - | - | -20.96M | -7.11M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Total assets | 9.27M | 16.75M | 32.30M | 39.31M | 59.71M |
| Intangible assets | 0.00M | 0.19M | 0.49M | 0.80M | 1.13M |
| Other current assets | - | - | - | 0.03M | 0.06M |
| Total liab | 3.57M | 3.11M | 2.84M | 3.72M | 3.32M |
| Total stockholder equity | 5.70M | 13.63M | 29.46M | 35.59M | 56.39M |
| Other current liab | - | - | - | 1.31M | 0.88M |
| Common stock | - | - | - | 62.52M | 63.06M |
| Capital stock | 60.99M | 60.99M | 60.99M | 62.52M | 63.06M |
| Retained earnings | -74.82M | -65.91M | -49.45M | -43.09M | -22.44M |
| Other liab | - | - | - | - | 0.09M |
| Good will | - | - | - | 0.00M | 13.67M |
| Other assets | - | - | - | 2.08M | 1.86M |
| Cash | 0.80M | 0.81M | 5.12M | 9.77M | 17.16M |
| Total current liabilities | 3.56M | 3.03M | 2.66M | 3.27M | 3.32M |
| Other stockholder equity | - | - | - | 14.79M | 14.42M |
| Property plant equipment | - | - | - | 19.71M | 19.34M |
| Total current assets | 2.64M | 5.36M | 10.59M | 16.71M | 24.28M |
| Net tangible assets | - | - | - | 34.78M | 42.07M |
| Net receivables | 0.45M | 0.78M | 0.62M | 0.92M | 1.17M |
| Inventory | 0.93M | 2.54M | 3.14M | 4.02M | 3.05M |
| Accounts payable | 0.38M | 0.64M | 1.21M | 1.17M | 1.93M |
| Non current assets total | 6.63M | 11.39M | 21.71M | 22.59M | 35.43M |
| Capital lease obligations | 0.08M | 0.19M | 0.41M | 0.68M | 0.03M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Investments | - | -0.05M | 0.13M | -1.15M | -10.00M |
| Change to liabilities | - | - | - | -1.28M | 0.69M |
| Total cashflows from investing activities | - | - | - | -1.15M | -6.83M |
| Net borrowings | -0.15M | -0.26M | -0.29M | -0.13M | -0.08M |
| Total cash from financing activities | -0.15M | -0.26M | -0.46M | -0.35M | -0.18M |
| Net income | -8.91M | -16.50M | -7.72M | -20.96M | -7.11M |
| Change in cash | -0.01M | -4.30M | -4.66M | -7.38M | -10.85M |
| Begin period cash flow | 0.81M | 5.12M | 9.77M | 17.16M | 28.01M |
| End period cash flow | 0.80M | 0.81M | 5.12M | 9.77M | 17.16M |
| Total cash from operating activities | -1.06M | -4.00M | -4.34M | -5.91M | -3.83M |
| Depreciation | 0.73M | 1.21M | 1.34M | 1.00M | 0.72M |
| Other cashflows from investing activities | - | - | - | 0.09M | 0.26M |
| Dividends paid | 0.00M | - | - | - | 0.00M |
| Change to inventory | 1.02M | 0.58M | -0.33M | -0.09M | 0.51M |
| Change to account receivables | 1.08M | 0.40M | 0.51M | 1.45M | -0.22M |
| Sale purchase of stock | - | 0.00M | -0.17M | -0.22M | -0.09M |
| Other cashflows from financing activities | - | - | - | - | -0.01M |
| Change to netincome | - | - | - | 13.95M | 1.56M |
| Capital expenditures | 0.00M | 0.05M | 0.06M | 0.17M | 0.43M |
| Change in working capital | 2.67M | 1.47M | -0.37M | 0.08M | 0.98M |
| Stock based compensation | 0.00M | 0.17M | 0.01M | 0.38M | 0.70M |
| Other non cash items | 0.01M | 0.03M | -0.02M | -0.16M | -0.03M |
| Free cash flow | -1.06M | -4.05M | -4.40M | -6.08M | -4.25M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(CAD) |
Price
(CAD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| RAMM RAMM Pharma Corp |
0.01 200.00% |
0.01 | - | - | 0.70 | 0.37 | 0.34 | -0.52 |
| GTII Green Thumb Industries Inc |
0.82 9.36% |
9.58 | 14.70 | 34.84 | 1.91 | 0.86 | 1.61 | 3.95 |
| CL Cresco Labs Inc |
0.01 1.27% |
0.80 | - | 105.26 | 0.70 | 0.99 | 1.32 | 42.44 |
| JUSH Jushi Holdings Inc |
- -% |
0.63 | - | 17.86 | 0.52 | 0.69 | 1.41 | 9.56 |
| GRIN Grown Rogue International Inc |
- -% |
0.50 | 23.50 | - | 3.62 | 4.10 | 3.13 | 11.19 |
RAMM Pharma Corp., together with its subsidiaries, operates in the pharmaceutical and medical product business in Uruguay and Poland. The company offers cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products; and pharmaceuticals, cosmetics, and nutraceutical products. It also engages in the resale of medical supplies products; and the sale of medical devices and consumables. The company was formerly known as MTC Growth Fund-I Inc. and changed its name to RAMM Pharma Corp. in October 2019. RAMM Pharma Corp. was incorporated in 1987 and is based in Toronto, Canada.
200, 82 Richmond St. East, Toronto, ON, Canada, M5C 1P1
416-848-7744
| Name | Title | Year Born |
|---|---|---|
| Mr. Jackie Peter Burnett | President, CEO & Chairman | NA |
| Mr. Jose Roldan | Interim CFO & Corporate Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...